What dose of albuterol should be administered via inhalation for a patient weighing 40.55 kg?

Albuterol Dosing for 40.55 kg Patient via Inhalation

For a patient weighing 40.55 kg, administer 6 mg of albuterol via nebulizer (0.15 mg/kg) every 20 minutes for 3 doses initially, then 6-10 mg every 1-4 hours as needed based on severity of exacerbation. 1

Initial Dosing Algorithm

For Acute Exacerbations (First Hour):

Weight-based calculation:

• 40.55 kg × 0.15 mg/kg = 6.08 mg per dose (round to 6 mg practically)
• Administer every 20 minutes for 3 doses
• Maximum single dose: 10 mg 1

Practical administration:

• Use two 2.5 mg vials + one 1.25 mg vial = 6.25 mg per treatment, OR
• Use 0.5% solution (5 mg/mL): 1.2 mL diluted to minimum 3 mL total volume
• Gas flow: 6-8 L/min
• Delivery time: 5-15 minutes 1

Maintenance Dosing (After Initial 3 Doses):

Based on severity:

• Mild-moderate exacerbation: 6 mg (0.15 mg/kg) every 1-4 hours as needed
• Severe exacerbation: 6-10 mg (0.15-0.3 mg/kg, max 10 mg) every 1-4 hours 1
• Continuous nebulization (if needed): 20 mg/hour (0.5 mg/kg/hour) 1

Alternative: MDI with Spacer

For mild-to-moderate exacerbations:

• 4-8 puffs (360-720 mcg) every 20 minutes for 3 doses
• Then 4-8 puffs every 1-4 hours as needed
• MDI plus valved holding chamber (VHC) is equally effective as nebulizer with proper technique 1, 2

Key Clinical Considerations

This patient falls into a transitional weight category where pediatric weight-based dosing (0.15 mg/kg = 6 mg) approaches but doesn't exceed the adult fixed-dose range (2.5-5 mg standard, up to 10 mg for severe cases). The guidelines consistently support weight-based dosing for children with a minimum of 2.5 mg, making 6 mg appropriate for this weight 1, 2, 1.

Severity-based adjustments:

• If FEV1 or PEF <40% predicted: Use higher end of dosing range (up to 10 mg) and consider continuous nebulization 1
• If FEV1 or PEF 40-69%: Standard weight-based dosing (6 mg) is appropriate 2
• Add ipratropium 0.5 mg to albuterol for severe exacerbations 1

Safety parameters:

• Monitor heart rate, blood pressure, tremor
• The FDA label notes doses above 3 mg in children associated with >10% heart rate increases, but guidelines support up to 10 mg for severe cases 3
• Research demonstrates 0.15 mg/kg dosing is both safe and more effective than lower doses (0.05 mg/kg) in severe asthma 4

Common pitfall: Using fixed adult doses (2.5 mg) in larger children/adolescents results in underdosing. Weight-based calculation is superior for this weight range, as supported by all major guidelines 1, 2, 1.